MDBpartners
Location:
MDBpartners
Website:
http://www.mdbpartners.com
Bio: CEO of life sciences strategic advisory and management consulting firm MD Becker Partners LLC
- Pause
- 0 new message(s) are waiting
-
-
MDBpartners
Micromet $MITI PR states company closed $80.5M offering today, Maxim Group (banker) subsequently issues PR stating $65.5M? #biotech
Mar. 17 at 1:38 PM
-
MDBpartners
Lesson to co's - don't predict FDA action: recall $MNKD exec saying FDA would approve drug by Jan. 16 @ http://ow.ly/1mOsz #biotech
Mar. 16 at 8:31 AM
-
MDBpartners
"MannKind Plummets; Could It Get Worse?" @ http://on.wsj.com/d3NHjJ by Tiernan Ray at Barron's $MNKD #biotech
Mar. 15 at 6:17 PM
-
MDBpartners
@howardlindzon Indeed, the Biotechnology Revolution continues. Let's connect in the near future about blog... #biotech $$
Mar. 9 at 6:14 PM
-
MDBpartners
RT @howardlindzon: This is the new BIOTECH filtered stream on Stocktwits for you http://stk.ly/ayvUZN $$
Mar. 9 at 6:08 PM
-
MDBpartners
NASDAQ Biotech Index closed up 2.7% the day Astellas offered to acquire $OSIP @ http://ow.ly/1giO1 #biotech
Mar. 9 at 6:06 PM
-
MDBpartners
After 52-wk high today, $FACT $ITMN could lead to further gains in NASDAQ Bio Index tomorrow #biotech
Mar. 9 at 6:04 PM
-
MDBpartners
$FACT traded < $6 a yr ago, 8/21/09 $BIIB offers to acquire at $15, 9/4/09 revises to $14.5, 12/3/09 ups offer to $17.5, now $ABT offers $27
Mar. 9 at 5:53 PM
-
MDBpartners
Busy day in #biotech: $ABT buying $FACT for $27, $ITMN rec'v positive FDA panel (up 59% after hours), and $MITI PR for ~$80M public offering
Mar. 9 at 5:27 PM
-
MDBpartners
"For Biotechnology in 2010, it’s Déjà vu All over Again" @ http://blog.mdbpartners.com/ #biotech $CTIC $DNDN $MNKD $ITMN
Mar. 8 at 7:08 AM
-
MDBpartners
RT @mhuckman: Breaking: Bristol CEO Jim Cornelius stepping down May 4th. Stays as Chmn. COO becomes CEO. $BMY
Mar. 2 at 4:06 PM
-
MDBpartners
Interesting to graph StockTwits.com comment stream for Osiris $OSIR against price action since Feb 24 http://stocktwits.com/t/OSIR #biotech
Mar. 2 at 1:54 PM
-
MDBpartners
NASDAQ Biotech Index reaches new 52-wk high driven by 50% gain in $OSIP and speculation among other M&A candidates w/ above avg vol #biotech
Mar. 1 at 3:29 PM
-
MDBpartners
Our review of the BMT Tandem Meetings titled "Gut Check Time for GVHD Companies" at http://ow.ly/1cdVR $OSIR $CELG SNGX.OB #biotech
Feb. 28 at 5:14 PM
-
MDBpartners
RT @adamfeuerstein: RT @ReutersLisaRx: FDA approves Shire drug for Gaucher disease, an alternative to Genzyme's Cerezyme $GENZ #biotech
Feb. 26 at 6:06 PM
-
MDBpartners
Gene Marcial's Inside Wall Street: Comeback Time for Bio-Defense Stocks? http://ow.ly/1bGbO $PIP SNGX.OB $SIGA AOLS.OB #biotech
Feb. 26 at 1:00 PM
-
MDBpartners
RT @adamfeuerstein: The Friday laffer -- $CBLI, the biomedreports pump and the Rodman PIPE. Nice job, everyone!
Feb. 26 at 11:18 AM
-
MDBpartners
$FOLD: Amicus Therapeutics Announces $18.5 Million Registered Direct Offering of Common Stock #biotech
Feb. 25 at 5:13 PM
-
MDBpartners
RT @adamfeuerstein: A bonus Biotech Stock Mailbag for Thurs: http://bit.ly/avjFpw $RNN $DCTH $XNPT and a Readers' Portfolio update.
Feb. 25 at 9:51 AM
-
MDBpartners
RT @adamfeuerstein: My "official" take on today's $OSIR call http://bit.ly/9s1vYl #biotech
Feb. 24 at 3:11 PM
-
MDBpartners
$OSIR durable CR rates: 35% vs. 30% (p=0.3) in the ITT population, 40% vs. 28% (p=0.08) in per protocol population = failed trial #biotech
Feb. 24 at 7:46 AM
-
MDBpartners
$ENZN Enzon's CEO the latest Carl Icahn casualty http://ow.ly/19PAQ #biotech
Feb. 22 at 7:49 AM
-
MDBpartners
$ENZN Jeffrey Buchalter has resigned as Chief Executive Officer and Director of Enzon #biotech
Feb. 22 at 7:40 AM
-
MDBpartners
Adam Feuerstein's Biotech Stock Mailbag: Health Discovery http://ow.ly/191w4 HDVY.OB $AMGN $ANX $DSCO $CLRT $DGX $ABT #biotech
Feb. 19 at 7:50 AM
-
MDBpartners
$CYCC Study in Clin Cancer Res demonstrates role for Cyclacel's seliciclib for hormone refractory breast cancer http://ow.ly/18d68 #biotech
Feb. 17 at 8:01 AM
-
MDBpartners
What would be the rationale for a 2nd panel at this point? RT @matthewherper: How much would a $DNDN a panel increase risk at this point?
Feb. 12 at 8:56 AM
-
MDBpartners
Yeah, I was never a big fan of efficient mkt hypo...LOL RT @matthewherper: It's above a worst-case scenario, actually. $ISIS
Feb. 10 at 1:24 PM
-
MDBpartners
RT @mhuckman: Leerink Swann on $ISIS cholesterol drug data:"Modest efficacy unable to make up for questionable...safety & tolerability."
Feb. 10 at 12:47 PM
-
MDBpartners
RT @mhuckman: $ISIS shares trading at new low on cholesterol drug study results. 5M shares traded already. $GENZ #biotech
Feb. 10 at 9:54 AM
-
MDBpartners
Attending $CYCC presentation at BIO CEO...standing room only
Feb. 8 at 10:39 AM
Pop out Stream
Keep the StockTwits stream handy without taking up valuable screen space. Create a mini pop out window of this stream.
Subcribe Via RSS
Get all the update information delivered directly to your web browser or newsreader.